Hugo Girard

997 total citations
18 papers, 810 citations indexed

About

Hugo Girard is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Hugo Girard has authored 18 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Pediatrics, Perinatology and Child Health and 6 papers in Oncology. Recurrent topics in Hugo Girard's work include Neonatal Health and Biochemistry (7 papers), Cancer therapeutics and mechanisms (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Hugo Girard is often cited by papers focused on Neonatal Health and Biochemistry (7 papers), Cancer therapeutics and mechanisms (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Hugo Girard collaborates with scholars based in Canada, France and United States. Hugo Girard's co-authors include Chantal Guillemette, Laurent Villeneuve, Louis‐Charles Fortier, Éric Lévesque, Michael H. Court, Qin Hao, David J. Greenblatt, Lisa L. von Moltke, Louis Përusse and Judith Bellemare and has published in prestigious journals such as Hepatology, Journal of Pharmacology and Experimental Therapeutics and European Urology.

In The Last Decade

Hugo Girard

16 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hugo Girard Canada 13 420 306 244 233 95 18 810
Anneke Nina Werk Germany 10 207 0.5× 221 0.7× 105 0.4× 211 0.9× 69 0.7× 12 590
Nobuko Ohmoto Japan 11 188 0.4× 165 0.5× 252 1.0× 470 2.0× 16 0.2× 13 774
Dany Chevalier France 15 192 0.5× 213 0.7× 109 0.4× 106 0.5× 25 0.3× 23 589
Masakazu Hirouchi Japan 12 132 0.3× 167 0.5× 216 0.9× 363 1.6× 12 0.1× 17 586
William J. Jusko United States 13 190 0.5× 118 0.4× 86 0.4× 90 0.4× 74 0.8× 17 607
Georgy Hartmann United States 9 113 0.3× 135 0.4× 145 0.6× 384 1.6× 13 0.1× 12 590
Shuichi Fukuen Japan 6 121 0.3× 226 0.7× 74 0.3× 150 0.6× 42 0.4× 6 419
Chaline Brown United States 7 659 1.6× 165 0.5× 230 0.9× 688 3.0× 11 0.1× 8 1.3k
Andreas K. Nuessler Germany 7 118 0.3× 189 0.6× 77 0.3× 184 0.8× 18 0.2× 13 476
Carla J. Gallagher United States 18 388 0.9× 196 0.6× 85 0.3× 130 0.6× 4 0.0× 32 834

Countries citing papers authored by Hugo Girard

Since Specialization
Citations

This map shows the geographic impact of Hugo Girard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo Girard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo Girard more than expected).

Fields of papers citing papers by Hugo Girard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo Girard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo Girard. The network helps show where Hugo Girard may publish in the future.

Co-authorship network of co-authors of Hugo Girard

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo Girard. A scholar is included among the top collaborators of Hugo Girard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo Girard. Hugo Girard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Girard, Hugo, Jean‐François Wiart, Luc Humbert, et al.. (2025). Main results of the IN CADAVER protocol: The value of using dried blood spots (DBS) in post-mortem forensic toxicology. Annales de Toxicologie Analytique. 37(1). S23–S23.
2.
Girard, Hugo, et al.. (2024). Psychometry as a tool to help determine total work incapacity. SPIRE - Sciences Po Institutional REpository. 15(3). 200456–200456.
3.
Gaulier, Jean‐Michel, Hugo Girard, Camille Richeval, et al.. (2023). Étude pilote du projet IN CADAVER : preuve de concept d’une voie future de la toxicologie post-mortem (et nouveau paradigme ?). Annales de Toxicologie Analytique. 35(2). S25–S25. 1 indexed citations
4.
Girard, Hugo, Olivier Potvin, Scott Nugent, et al.. (2017). Faster progression from MCI to probable AD for carriers of a single-nucleotide polymorphism associated with type 2 diabetes. Neurobiology of Aging. 64. 157.e11–157.e17. 15 indexed citations
5.
Audet‐Walsh, Étienne, Judith Bellemare, Geneviève Nadeau, et al.. (2011). SRD5A Polymorphisms and Biochemical Failure After Radical Prostatectomy. European Urology. 60(6). 1226–1234. 36 indexed citations
6.
Bellemare, Judith, Mélanie Rouleau, Hugo Girard, Mario Harvey, & Chantal Guillemette. (2010). Alternatively Spliced Products of the UGT1A Gene Interact with the Enzymatically Active Proteins to Inhibit Glucuronosyltransferase Activity In Vitro. Drug Metabolism and Disposition. 38(10). 1785–1789. 21 indexed citations
7.
Lévesque, Éric, Vincent Ménard, Isabelle Laverdière, et al.. (2010). Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidation. Pharmacogenetics and Genomics. 20(3). 195–210. 20 indexed citations
8.
Ménard, Vincent, Hugo Girard, Mario Harvey, Louis Përusse, & Chantal Guillemette. (2009). Analysis of inherited genetic variations at theUGT1locus in the French-Canadian population. Human Mutation. 30(4). 677–687. 29 indexed citations
9.
Girard, Hugo, Lesley M. Butler, Laurent Villeneuve, et al.. (2008). UGT1A1 and UGT1A9 functional variants, meat intake, and colon cancer, among Caucasians and African-Americans. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 644(1-2). 56–63. 44 indexed citations
11.
Lévesque, Éric, et al.. (2006). Regulation of the UGT1A1 bilirubin-conjugating pathway: Role of a new splicing event at the UGT1A locus. Hepatology. 45(1). 128–138. 77 indexed citations
12.
Girard, Hugo, Laurent Villeneuve, Michael H. Court, et al.. (2006). THE NOVEL UGT1A9 INTRONIC I399 POLYMORPHISM APPEARS AS A PREDICTOR OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN GLUCURONIDATION LEVELS IN THE LIVER. Drug Metabolism and Disposition. 34(7). 1220–1228. 61 indexed citations
13.
Girard, Hugo, Michael H. Court, Louis‐Charles Fortier, et al.. (2005). UGT1A1 polymorphisms are important determinants of dietary carcinogen detoxification in the liver†‡. Hepatology. 42(2). 448–457. 61 indexed citations
14.
Barbier, Olivier, Hugo Girard, Yusuke Inoue, et al.. (2004). Hepatic Expression of the UGT1A9 Gene Is Governed by Hepatocyte Nuclear Factor 4α. Molecular Pharmacology. 67(1). 241–249. 52 indexed citations
15.
Girard, Hugo, Michael H. Court, Olivier Bernard, et al.. (2004). Identification of common polymorphisms in the promoter of the UGT1A9 gene. Pharmacogenetics. 14(8). 501–515. 170 indexed citations
17.
Girard, Hugo, et al.. (1954). Des divers types de virus aphteux souches pures et «mutations». Bulletin de l Académie vétérinaire de France. 107(3). 117–124. 1 indexed citations
18.
Girard, Hugo, et al.. (1953). [Biological study of the electrophoretically-separated fractions of lymph from cattle with foot and mouth disease].. PubMed. 17(4-5). 239–51. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026